Page last updated: 2024-10-22

am 251 and Alveolar Bone Atrophy

am 251 has been researched along with Alveolar Bone Atrophy in 1 studies

AM 251: an analog of SR141716A; structure given in first source
AM-251 : A carbohydrazide obtained by formal condensation of the carboxy group of 1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-1H-pyrazole-3-carboxylic acid with the amino group of 1-aminopiperidine. An antagonist at the CB1 cannabinoid receptor.

Research Excerpts

ExcerptRelevanceReference
"Corticosterone plasma levels, locomotor activity, adrenal gland weight and bone loss were increased in periodontitis and stress groups, and there was also less weight gain."7.78Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat. ( De Laurentiis, A; Elverdin, JC; Rettori, E; Rettori, V; Zorrilla Zubilete, M, 2012)
"Corticosterone plasma levels, locomotor activity, adrenal gland weight and bone loss were increased in periodontitis and stress groups, and there was also less weight gain."3.78Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat. ( De Laurentiis, A; Elverdin, JC; Rettori, E; Rettori, V; Zorrilla Zubilete, M, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rettori, E1
De Laurentiis, A1
Zorrilla Zubilete, M1
Rettori, V1
Elverdin, JC1

Other Studies

1 other study available for am 251 and Alveolar Bone Atrophy

ArticleYear
Anti-inflammatory effect of the endocannabinoid anandamide in experimental periodontitis and stress in the rat.
    Neuroimmunomodulation, 2012, Volume: 19, Issue:5

    Topics: Alveolar Bone Loss; Animals; Anti-Inflammatory Agents; Arachidonic Acids; Body Weight; Cannabinoid R

2012